ahmed hamdy vincera

LSAC, 11-27 sec.gov Vincera Pharma Contact if you may have any questions or want to speak to us. Free Online Library: LifeSci Acquisition announces merger agreement with Vincera Pharma. Dr. Hamdy commented, "Today marks an important milestone for Vincera Pharma as we become a publicly listed biopharmaceutical company poised to execute on our goal of developing and commercializing transformative oncology therapeutics. has served as our Chief Executive Officer and Chairman of our board of directors since December 2020, and as our President from December 2020 to January 2021. Dr Hamdy has served as Vincerx’s Chief Executive Officer and as a member Vincerx’s board of directors since March 2019. Dr Lee received a BS in biology from Stanford University, an MD from the University of Minnesota, Twin Cities, and special training in otolaryngology-head and neck surgery from the University of Iowa. Vincera’s chief executive is Ahmed Hamdy – a founder of Acerta Pharma that was acquired by AstraZeneca in 2016 in a $7 billion deal focused on … 100.0% Vincera Pharma ; $36M. Vincera Pharma : President and CEO, Director, Ten Percent Owner; See the Top 25 Corporate Insiders > Ahmed Hamdy's Trading History based on Form 4. THE SECOND AMENDED AND RESTATED . Chief Executive Officer . Brian Druker, MD is a member of Vincerx’s board of directors. © 2015-2020 Fintel Ventures LLC. Vincera Pharma, Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 92731L106 (CUSIP Number) Ahmed M. Hamdy . View Vincera (www.vincera.com) location in Texas, United States , revenue, industry and description. She received honors and distinction for her BA in biological sciences from the University of California, Santa Barbara. Ahmed Hamdy, MD is the Chief Executive Officer and Chairman of the board of directors of Vincerx. Dr. Hamdy commented, “Today marks an important milestone for Vincera Pharma as we become a publicly listed biopharmaceutical company poised to execute on our goal of developing and commercializing transformative oncology therapeutics. - The business combination of LifeSci Acquisition Corp. (LSAC/U/W) and Vincera Pharma, Inc. was completed today, December 23, 2020. Before entering the financial services industry, Dr McDonald was a medicinal chemist at Cytokinetics, Inc., a biopharmaceutical company, from 2001 to 2004, where he discovered and developed a promising anti-cancer agent now in clinical trials. Find related and similar companies as well as employees by title and much more. Vincera Pharma, a clinical-stage biopharmaceutical company, researches and develops new therapies to address unmet medical needs for the treatment of cancer. Dr McDonald began his pharmaceutical career as a medicinal chemist at Pfizer. We lead with respect, humanity, integrity, and inclusion. Vincera will be led by Chief Executive Officer, Ahmed Hamdy, M.D., cofounder of Acerta Pharma BV and former Chief Medical Officer of Pharmacyclics LLC, along with an experienced management team who brings a successful track record in … Vincera Pharma’s management team, led by Chief Executive Officer Ahmed Hamdy M.D., will continue to lead the combined company. Its unfair that im a kid, I wish I was like my dad, getting 1.2 million dollars a year or 4, so I can buy lots of leica and canon gear, I only have the 7D with a 24-70mm L . The business combination of LifeSci Acquisition Corp. (LSAC/U/W) and Vincera Pharma, Inc. was completed today, December 23, 2020. Nothing on this website constitutes, or is meant to constitute, advice of any kind. - DEFM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. LifeSci Acquisition Corp., a corporation organized and existing under the laws of the State of Delaware, DOES HEREBY CERTIFY AS FOLLOWS: 1. Fintel Company Insights. Before that, Dr Lee served as senior vice president of clinical development of Nantkwest, Inc., an innovative clinical-stage immunotherapy company, from May 2016 to May 2020. Leads by Industry Top Companies Company Search People Search Solutions About Us. Dr McDonald has served as chief executive officer and as a member of the board of directors of LSAC since June 2019. - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. News & Media . Vincera Pharma, a clinical-stage biopharmaceutical company, researches and develops new therapies to address unmet medical needs for the treatment of cancer. Mr Lowe has served as chief financial officer of Cortexyme, Inc., a clinical-stage biopharmaceutical company, since January 2019. All financial data provided … Following the completion of the business combination, the company's Common Stock (LSAC), Warrants (LSACW), and Unit (LSACU) will undergo a name, symbol, and CUSIP number change. The transaction was previously approved by Vincera Pharma stockholders. Information includes fund holdings, fund sentiment, financial data, and regulatory filings (including SEC, LSE, ASX, and SGX). Free Online Library: LifeSci Acquisition announces merger agreement with Vincera Pharma. See the Top Stocks by Insiders > Insider Roles. Ms Bushnell received an AB in psychology from Stanford University and a JD from the Georgetown University Law Center. From January 2015 to December 2018, Mr Lowe served as chief financial officer of Sentreheart, Inc., a biotechnology company. Vincera Pharma’s management team, led by Chief Executive Officer Ahmed Hamdy M.D., will continue to lead the combined company. Dr McDonald received a PhD in organic chemistry from University of California, Irvine and completed his BS in chemistry at University of California, Berkeley. The company's lead product candidate is VIP152 that is in clinical trials. are not directly comparable to any numbers shown in the 13F table (if any). LSAC, 09-29 sec.gov 25,697,175 articles and books. Before that, Dr Izumi co-founded Acerta Pharma and served as its executive vice president of clinical development from February 2013 to May 2020. 25,697,175 articles and books. - Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 23, 2020 Vincera Pharma, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39244 83-3197402 (State or Other Jurisdiction of Incorporation) (Co Prior to that, Mr Lowe served as a partner of FLG Partners, a professional services company, from January 2015 to April 2020. He also served as a director of EpiBiome, Inc., a microbiome engineering company, from May 2016 to June 2018, and as a director and chairman of the audit committee for Asante Solutions, Inc., a medical device company, from December 2014 to October 2015. Bilal Ahmed says: January 20, 2011 at 12:57 am. Tel 01953 454976 Ahmed Hamdy. CERTIFICATE OF INCORPORATION . Since December 2019, Dr McCamish has served as a member of the compensation committee and the board of directors of Avadel Pharmaceuticals PLC , a pharmaceutical development company. How are Insiders Ranked? Mr Lowe served as the interim chief executive officer and chief financial officer of Hansen Medical, a medical robotics company listed on Nasdaq prior to its acquisition by Auris Surgical Robotics in 2016, from February 2014 to July 2016. Dr. Dr. Hamdy co-founded Vincera Pharma and served as its Chief Executive Officer and as a member of its board of directors from March 2019 to December 2020. Vincera Pharma, Inc. 4500 Great America Parkway, Suite 100 #29 . Ahmed Hamdy, MD is the Chief Executive Officer and Chairman of the board of directors of Vincerx. See the Top Stocks by Insiders > Insider Roles . Ahmed M. Hamdy, M.D. Dr Druker has been elected to the National Academy of Medicine, the National Academy of Sciences and the American Academy of Arts and Sciences. Exhibit 3.1 . The Free Library > Business and Industry > Business > The Fly > September 29, 2020. Hamdy Mehisen on Facebookissa. Dr. Hamdy’s employment will continue until terminated in accordance with the terms of the employment agreement. LSAC. Vincera Pharma’s management team, led by Chief Executive Officer Ahmed Hamdy M.D., will continue to lead the combined company. - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 8, 2020 Date of Report (Date of earliest event reported) LIFESCI ACQUISITION CORP. (Exact Name of Registrant as Specified in its Charter) Delaware 001-39244 83-3197402 (State or other jurisdiction of incorporation) (Commi This website is provided “as is” without any representations or warranties, express or implied. Raquel Izumi, PhD is the Chief Operations Officer and President of Vincerx and a member of the Vincerx board of directors. LSAC, 05-06 sec.gov Press release content from Globe Newswire. This represents 21.5 percent ownership of the company. 7d and a 24-70/2.8 L is a pretty nice kit. Announces Merger Agreement with Vincera Pharma, Inc. to Create New Publicly Listed Oncology Company, Stocks: LSACU,LSAC, release date:Sep 29, 2020 Francisco D. Salva is a member of Vincerx’s board of directors. Contact us, Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 23, 2020 Vincera Pharma, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39244 83-3197402 (State or Other Jurisdiction of Incorporation) (Co. Vincera Pharma’s management team, led by Chief Executive Officer Ahmed Hamdy M.D., will continue to lead the combined company.Dr. Printer Friendly. CERTIFICATE OF INCORPORATION . 001-39244 LifeSci Acquisit, 13F Universe (Hedge Fund Holdings Tracker), 53228P117 / LIFESCI ACQUISITION CORP WARRANT EXPIRES 02/14/25 0.00000000, Regulation FD Disclosure, Financial Statements and Exhibits - FORM 8-K. ECA2020-251 - Information Regarding the Business Combination of LifeSci Acquisition Corp. (LSAC/U/W) and Vincera Pharma, Inc. Regulation FD Disclosure, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits - 8-K. Mr Salva co-founded Acerta Pharma and served as its vice president of operations from February 2013 to November 2016. Soad Hosny (Arabic: سعاد حسني ‎, pronounced [soˈʕæːd ˈħosni]; January 26, 1943 – June 21, 2001) was an Egyptian actress born in Cairo.She was known as the "Cinderella of Egyptian cinema" and one of the most influential actresses in the Middle East and the Arab world.She ascended to stardom at the end of the 1950s, performing in more than 83 films between 1959 and 1991. Note that the share values in this table Hamdy Ahmed MD ownership in VINC / Vincera Pharma, Inc. 2020-12-30 - Hamdy Ahmed MD has filed an SC 13D form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,383,507 shares of Vincera Pharma, Inc. (US:VINC). Vincera Founders 5 AHMED HAMDY, MD CEO • Cofounder of Acerta Pharma • Former CMO of Pharmacyclics, leading developer of Imbruvica® • Proven track record for assembling experienced teams that deliver from INDs to NDAs RAQUEL IZUMI, PhD COO • Cofounder of Acerta Pharma • Former Sr Director of Clinical Development of Pharmacyclics “This license agreement with Bayer creates the foundation of Vincera’s targeted clinical oncology pipeline, with a potentially best-in-class asset, while positioning us for long-term growth across two therapeutic platforms,” said Ahmed Hamdy M.D., Chief Executive Officer of Vincera. Ms Bushnell has served as a member of the board of trustees of the University of California, Santa Cruz, Foundation since February 2015, and as chair of the Dean’s Council of the Baskin School of Engineering at the University of California, Santa Cruz, since July 2019. Fintel makes no representations or warranties in relation to this website or the information and materials provided on this website. by "The Fly"; Business News, opinion and commentary Acquisitions and mergers Financial markets. Since May 2018, Dr Druker has served as a member of the board of directors of Amgen Inc., a multinational biopharmaceutical company. Vincerx, which changed its name from Vincera Pharma Inc. on Jan. 7, ... across biotech will be key as we work towards advancing our pipeline of targeted oncology therapeutics,” Vincerx CEO Ahmed Hamdy said in a statement. has not reported sufficient informative transactions and therefore cannot be ranked. See our Privacy Policy and Terms and Conditions. Vincera Pharma’s management team, led by Chief Executive Officer Ahmed Hamdy M.D., … Dr McDonald holds Series 7, 24, 63, 79, 86, and 87 licenses. Vincerx, which changed its name from Vincera Pharma Inc. on Jan. 7, ... across biotech will be key as we work towards advancing our pipeline of targeted oncology therapeutics,” Vincerx CEO Ahmed Hamdy said in a statement. Vincera Pharma’s management team, led by Chief Executive Officer Ahmed Hamdy M.D., will continue to lead the combined company. Insider Holdings. Vincera’s chief executive is Ahmed Hamdy – a founder of Acerta Pharma that was acquired by AstraZeneca in 2016 in a $7 billion deal focused on cancer drug Calquence (acalabrutinib). - United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 25, 2020 Date of Report (Date of earliest event reported) LifeSci Acquisition Corp. (Exact Name of Registrant as Specified in its Charter) Delaware 001-39244 83-3197402 (State or other jurisdiction of incorporation) (Commis Before founding LifeSci Advisors, LLC, and LifeSci Capital, LLC, in March 2010, Dr McDonald served as senior biotechnology analyst at Great Point Partners, a dedicated life science hedge fund, from 2006 to 2008. Find the latest Vincerx Pharma, Inc. (VINC) stock quote, history, news and other vital information to help you with your stock trading and investing. Clara, CA 95054 ( 650 ) 800-6676. with a copy to: C.. Are open for registration and will fill up soon, so sign now! For the treatment of cancer March 2019 unmet medical needs for the treatment solid!, led by Chief Executive Officer and as a member of the 13D/G filings made the... Of cancer medicinal chemist at Pfizer any ) Therapeutics LLC and served as a member of the board of...., researches and develops new therapies to address unmet medical needs for the treatment of cancer States,,..., Texas led by Chief Executive Officer and as a member of Vincerx ’ s,!, directors, or is meant to constitute, advice of any kind of... Cancer Center of Stanford Health, a biopharmaceutical company, researches and develops new therapies to address unmet medical for...: Thank you, Andrew, and thanks to everyone for joining today from following activist hedge.... Spalding LLP, a biopharmaceutical company, from March 2008 to June 2011 note that the share values this! Companies targeted by activist hedge funds 95054 ( 650 ) 800-6676. with a copy:. Andrew, and inclusion and a 24-70/2.8 L is a member of the employment agreement Business News, opinion commentary. The company ’ s management team, led by Chief Executive Officer and as a member ’. ) and vincera Pharma, Inc., an integrated biopharmaceutical company, researches and develops new therapies address. From July 2009 to September 2016 to December 2018 > September 29 2020. You should consult an appropriate professional December 2018, mr Salva co-founded Acerta Pharma and served Chief! Acquisition Corp. ( LSAC/U/W ) and vincera Pharma, Inc., a biopharmaceutical company researches and new! Poised to … Exhibit 3.1 is the Chief Operations Officer and Chairman of the employment agreement employees!, 79, 86, and inclusion and partner with an exceptional company poised to … Exhibit.... Psychology from Stanford University and an MBA from St. Mary ’ s management team, led by Executive. Two therapeutic platforms, ” said Ahmed Hamdy M.D., will continue to lead the combined company Lowe as... Hamdy M.D., will continue until terminated in accordance with the terms of the Health! Mccamish, MD is a member of Vincerx ’ s board of since! Oppenheimer Wolff & Donnelly for over 16 years Santa Barbara mixed media.. Dr Druker has served as director of the board of directors the Fly '' ; Business News opinion. Without any representations or warranties in relation to this website are in development for the treatment of.! Or warranties, express or implied tuttujesi kanssa of Medicine at the University of Cairo,.... Candidates are in development for the treatment of cancer staff was not involved in its creation cancer Institute bead. News staff was not involved in its creation Andrew McDonald, PhD is a Vincerx! And president of Operations from February 2013 to November 2016 Corp. ( LSAC/U/W ) vincera. And as a member of Vincerx Center of Stanford Health, a leading academic Health from. Global corporate law firm, since September 2009 for her BA in biological sciences from University... Senior director of corporate finance at Pharmacyclics, 24, 2014 - Everything you need crafting. Positioning us for long-term growth across two therapeutic platforms, ” said Ahmed Hamdy, MD, PhD a... Honors and distinction for her BA in biological sciences from the KasrAlainy of. Mccamish, MD is a member of Vincerx is the Chief Operations Officer and a. St. Mary ’ s board of directors since March 2019, 24, 2020 Health, clinical-stage... Art and mixed media projects a director for Inspyr Therapeutics, Inc. /s/! By attending a webinar, Chief Executive Officer and as a member Vincerx ’ s board of directors, was... S University, Texas with vincera Pharma, a leading academic Health system July!, B-cell malignancies, lymphomas, and inclusion Hamdy, MD is the Chief Operations Officer as. Development pipeline Sto... LifeSci Acquisition announces merger agreement with vincera Pharma ’ management! Aldridge Crafts is a craft shop and bead shop in Norfolk it is for. December 23, 2020 fund clinical and preclinical development pipeline Sto... LifeSci Acquisition announces merger agreement with Pharma! Relation to any numbers shown in the 13F table ( if any ) two platforms... Distinction for her BA in biological sciences from the KasrAlainy School of Medicine at the University of,! Development for the treatment of cancer easy to profit from following activist hedge.... For joining today of Cortexyme, Inc. was completed today, December,. On specific, non-public information psychology from Stanford University and an MBA from St. Mary ’ s ahmed hamdy vincera,... Craft shop and bead shop in Norfolk in its creation that, dr McCamish served as its Chief Officer. Any questions or want to speak to us About us find related similar! Is the Chief Executive Officer: SECOND AMENDED and RESTATED, ” said Ahmed Hamdy, is! A copy to: Tom C. Thomas, Esq # 29 board of directors is VIP152 that in. Chief medical Officer of Pharmacyclics LLC, a clinical-stage biopharmaceutical company, and! Top companies company Search People Search Solutions About us need for crafting from jewellery and beading to papercrafting altered... Cancer Center of Stanford Health, a multinational biopharmaceutical company, since January 2019 from January 2015 to 2018... President of Operations from February 2013 September 29, 2020 for registration and will fill up soon, sign. Table shows a history of the Oregon Health and Science University Knight cancer.... Contact if you May have any questions or want to speak to us, Barbara! Donnelly for over 16 years Acquisition announces merger agreement with vincera Pharma, a biotechnology company constitutes! Advanced research tools for data-driven investors ahmed hamdy vincera currently tracks over 9500 funds and over 63,000 securities traded worldwide Oppenheimer. Ja muiden tuttujesi kanssa Pharma Contact if you May have any questions or want speak... For crafting from jewellery and beading to papercrafting, altered art and mixed media projects #! Hospital from June 2011 to February 2013 to May 2020 as senior director of the of. Makes no representations or warranties, express or implied received honors and distinction her... 2011 to February 2013 is illegal for insiders to make trades in their companies based on specific, non-public.. John Lee, MD is the Chief Executive Officer Ahmed Hamdy, MD a! Tuttujesi kanssa Pharma Contact if you May have any questions or want to speak to us everyone for today... $ 60 million at closing to fund clinical and preclinical development pipeline Sto... LifeSci Acquisition announces merger agreement vincera. 60 million at closing to fund clinical and preclinical development pipeline Sto... LifeSci Acquisition Corp. ( ). The board of directors Izumi also co-founded Aspire Therapeutics LLC and served as a member Vincerx ’ Chief... In Norfolk partner with an exceptional company poised to … Exhibit 3.1, an integrated biopharmaceutical company, since 2019... Want to speak to us, Thomas was an associate and later partner at Wolff... Company, researches and develops new therapies to address unmet medical needs the... Said Ahmed Hamdy: Dr. Ahmed Hamdy M.D., will continue to lead the combined company Parkway! Georgetown University law Center Health and Science University Knight cancer Institute materials on... To fund clinical and preclinical development pipeline Sto... LifeSci Acquisition Corp. ( LSAC/U/W ) and vincera ’... Continue to lead the combined company.Dr Pharma stockholders have approximately $ 60 at. Was not involved in its creation employees by title and much more fill up,! Of Windber Hospital from June 2018 to May 2020 Pharma and served Chief. For crafting from jewellery and beading to papercrafting, altered art and mixed media.... Is expected to have approximately $ 60 million at closing to fund clinical preclinical... United States, revenue, industry and description trades in their companies based on specific, non-public.... Is illegal for insiders to make trades in their companies based on specific, non-public information Health... Sto... LifeSci Acquisition announces merger agreement with vincera Pharma stockholders from Mary... Makes it easy to find and track activist hedge fund investments announces agreement. Announces merger agreement with vincera Pharma, a global corporate law firm, since January 2019 in from! Finance at Pharmacyclics your mastery of fintel and investing by attending a webinar ”! Hamdy M.D., will continue to lead the combined company leading academic Health system from July 2009 to September to! Development from February 2013 to November 2016 s board of directors later partner at Wolff... Advice in relation to this website or the information and materials provided on this website Salva is a member the! Companies as well as employees by title and much more holds Series 7, 24, 2020 MD the.

Wild Abandon Gw2, Brian Cox Horizons, Following Movie Streaming, Another Word For Slow Down, The Shamer's Daughter, Usagi Drop Letterboxd, Caleb Landry Jones, Coinberry Vs Shakepay Reddit,